![Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer | Scientific Reports Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-017-08436-6/MediaObjects/41598_2017_8436_Fig1_HTML.jpg)
Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer | Scientific Reports
![l-asparaginase and 6-diazo-5-oxo-l-norleucine synergistically inhibit the growth of glioblastoma cells | SpringerLink l-asparaginase and 6-diazo-5-oxo-l-norleucine synergistically inhibit the growth of glioblastoma cells | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11060-019-03351-4/MediaObjects/11060_2019_3351_Fig4a_HTML.png)
l-asparaginase and 6-diazo-5-oxo-l-norleucine synergistically inhibit the growth of glioblastoma cells | SpringerLink
![Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy](https://static.hindawi.com/articles/bmri/volume-2015/690492/figures/690492.fig.001.jpg)
Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy
![157-03-9・6-Diazo-5-oxo-L-norleucine・045-32441・041-32443[Detail Information] | [Life Science]|Laboratory Chemicals-FUJIFILM Wako Chemicals U.S.A. Corporation 157-03-9・6-Diazo-5-oxo-L-norleucine・045-32441・041-32443[Detail Information] | [Life Science]|Laboratory Chemicals-FUJIFILM Wako Chemicals U.S.A. Corporation](https://labchem-wako.fujifilm.com/sc/06/045-32441.jpg)
157-03-9・6-Diazo-5-oxo-L-norleucine・045-32441・041-32443[Detail Information] | [Life Science]|Laboratory Chemicals-FUJIFILM Wako Chemicals U.S.A. Corporation
![The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells](https://www.spandidos-publications.com/article_images/ol/20/3/ol-20-03-3053-g00.jpg)
The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells
![Chemical structure of 6-diazo-5-oxo-l-norleucine (DON) and the prodrug... | Download Scientific Diagram Chemical structure of 6-diazo-5-oxo-l-norleucine (DON) and the prodrug... | Download Scientific Diagram](https://www.researchgate.net/publication/336184564/figure/fig1/AS:812324101312514@1570684566869/Chemical-structure-of-6-diazo-5-oxo-l-norleucine-DON-and-the-prodrug-JHU-083-Ethyl.png)
Chemical structure of 6-diazo-5-oxo-l-norleucine (DON) and the prodrug... | Download Scientific Diagram
![Chemical reactivity of 6-diazo-5-oxo-l-norleucine (DON) catalyzed by metalloporphyrins (Fe,Ru) - ScienceDirect Chemical reactivity of 6-diazo-5-oxo-l-norleucine (DON) catalyzed by metalloporphyrins (Fe,Ru) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0040402010006459-fx1.jpg)
Chemical reactivity of 6-diazo-5-oxo-l-norleucine (DON) catalyzed by metalloporphyrins (Fe,Ru) - ScienceDirect
![Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs. - Abstract - Europe PMC Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs. - Abstract - Europe PMC](https://europepmc.org/articles/PMC8025739/bin/nihms-1027177-t0012.jpg)
Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs. - Abstract - Europe PMC
![Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis | Journal of Virology Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis | Journal of Virology](https://journals.asm.org/cms/10.1128/jvi.01045-16/asset/e331e640-e37a-4f22-9abb-bff13c1611e9/assets/graphic/zjv9991820110006.jpeg)
Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis | Journal of Virology
![WO2016112386A1 - Methods for bioanalysis of 6-diazo-5-oxo-l-norleucine (don) and other glutamine antagonists - Google Patents WO2016112386A1 - Methods for bioanalysis of 6-diazo-5-oxo-l-norleucine (don) and other glutamine antagonists - Google Patents](https://patentimages.storage.googleapis.com/0c/ac/6a/a2518581b2033c/imgf000021_0002.png)
WO2016112386A1 - Methods for bioanalysis of 6-diazo-5-oxo-l-norleucine (don) and other glutamine antagonists - Google Patents
![Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma | Journal of Medicinal Chemistry Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.6b01069/asset/images/large/jm-2016-01069f_0001.jpeg)
Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma | Journal of Medicinal Chemistry
![Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs | Journal of Medicinal Chemistry Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.8b02009/asset/images/medium/jm-2018-02009g_0007.gif)